• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

Introduction to 3-Amino-4,5-dimethylbenzene-1-sulfonamide (CAS No. 101251-33-6)

3-Amino-4,5-dimethylbenzene-1-sulfonamide, identified by its Chemical Abstracts Service (CAS) number 101251-33-6, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the class of sulfonamides, which are well-known for their diverse biological activities and therapeutic applications. The structural features of 3-amino-4,5-dimethylbenzene-1-sulfonamide, including its aromatic ring system modified by amino and sulfonamide functional groups, as well as the presence of methyl substituents at the 4th and 5th positions, contribute to its unique chemical properties and potential biological functions.

The sulfonamide moiety (-SO?NH?) in 3-amino-4,5-dimethylbenzene-1-sulfonamide is a key pharmacophore that interacts with biological targets such as enzymes and receptors. Sulfonamides have a long history of use in medicine, particularly as antimicrobial agents, due to their ability to inhibit bacterial growth by interfering with folic acid synthesis. The structural variability within this class allows for the design of compounds with tailored biological activities, making sulfonamides a valuable scaffold for drug discovery.

In recent years, there has been increasing interest in exploring the therapeutic potential of derivatives of 3-amino-4,5-dimethylbenzene-1-sulfonamide. Research has highlighted its potential in various pharmacological contexts, including anti-inflammatory, anticancer, and antimicrobial applications. The presence of both amino and sulfonamide groups in the molecule enables multiple modes of interaction with biological targets, which can be exploited to develop novel therapeutic strategies.

One of the most compelling aspects of 3-amino-4,5-dimethylbenzene-1-sulfonamide is its versatility as a chemical scaffold. By modifying its structure, researchers can fine-tune its biological activity to target specific diseases or conditions. For instance, studies have demonstrated that derivatives of this compound can exhibit inhibitory effects on certain enzymes involved in cancer progression. The methyl substituents at the 4th and 5th positions of the benzene ring may play a crucial role in determining the compound's binding affinity and selectivity towards biological targets.

The synthesis of 3-amino-4,5-dimethylbenzene-1-sulfonamide involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. The process typically begins with the preparation of a dimethyl-substituted benzene derivative, followed by sulfonation and subsequent amination. Advanced synthetic techniques, such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to improve the efficiency and scalability of production.

From a computational chemistry perspective, the molecular properties of 3-amino-4,5-dimethylbenzene-1-sulfonamide have been extensively studied using various modeling techniques. Quantum mechanical calculations have provided insights into its electronic structure and reactivity, while molecular dynamics simulations have helped elucidate its interactions with biological targets. These computational studies are essential for guiding experimental efforts and optimizing the design of new derivatives.

The pharmacological evaluation of 3-amino-4,5-dimethylbenzene-1-sulfonamide has revealed several promising applications. In vitro studies have shown that this compound can inhibit the activity of enzymes such as dihydrofolate reductase (DHFR), which is crucial for bacterial proliferation. Additionally, it has demonstrated potential in modulating inflammatory pathways by interacting with cytokine receptors and signaling molecules. These findings suggest that 3-amino-4,5-dimethylbenzene-1-sulfonamide could be a valuable candidate for further development into therapeutic agents.

Recent advances in drug delivery systems have also opened new avenues for utilizing 3-amino-4,5-dimethylbenzene-1-sulfonamide. Nanoparticle-based formulations have been explored as vehicles for delivering this compound to target tissues with high efficiency. Such systems can enhance bioavailability and reduce side effects associated with traditional oral or intravenous administration methods. The encapsulation of 3-amino-4,5-dimethylbenzene-1-sulfonamide within biodegradable polymers or liposomes has shown particular promise in preclinical studies.

The regulatory landscape for developing new pharmaceuticals based on compounds like 3-amino-4,5-dimethylbenzene-1-sulfonamide is stringent but well-established. Clinical trials are essential for evaluating the safety and efficacy of potential drugs before they can be approved for human use. Researchers are currently conducting Phase I and II clinical trials to assess the tolerability and pharmacokinetic profile of derivatives of this compound in human subjects.

The future directions for research on 3-amino-4,5-dimethylbenzene-1-sulfonamide are multifaceted. Further exploration of its structural analogs is expected to yield novel compounds with enhanced therapeutic properties. Additionally, interdisciplinary approaches combining organic chemistry, medicinal chemistry, biochemistry, and computational biology will be crucial in unraveling its full potential.

In conclusion,3-amino-4,5-dimethylbenzene-1-sulfonamide (CAS No. 101251-33-6) is a versatile compound with significant promise in pharmaceutical applications. Its unique structural features make it an attractive scaffold for drug discovery，and ongoing research continues to uncover new therapeutic possibilities。With continued innovation，this compound is poised to make meaningful contributions to modern medicine.

• 6973-09-7(5-amino-2-methylbenzene-1-sulfonamide)
• 71503-16-7(Benzenesulfonamide,2-amino-3-methyl-)
• 34684-45-2(5-amino-2,4-dimethylbenzene-1-sulfonamide)
• 10311-44-1(3-amino-2,4-dimethylbenzene-1-sulfonamide)
• 7356-89-0(Benzenesulfonamide,4-amino-3,5-dimethyl-)
• 53297-70-4(4-Amino-3-methylbenzenesulfonamide)
• 6274-28-8(3-amino-4-methylbenzene-1-sulfonamide)
• 94109-57-6(4-amino-2-methylbenzene-1-sulfonamide)
• 37559-29-8(3-amino-4-ethylbenzene-1-sulfonamide)
• 252562-03-1(Acetamide,N-[4-(aminosulfonyl)-2-methylphenyl]-)